Vitamin D, obesity, and risk of diabetes

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 5, 2014, Pages 361-362

  Boucher, Barbara ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; C PEPTIDE;

CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; LETTER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; FISH; INSULIN RELEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; FEMALE; MALE;

FEMALE; HUMANS; MALE; OBESITY; VITAMIN D;

EID: 84899682826     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70083-X     Document Type: Letter

References (5)

1. Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG Vitamin D concentration, obesity, and risk of diabetes: a Mendelian randomisation study. Lancet Diabetes Endocrinol 2014, 2:298-306.
2. Pilz S, Gaksh M, Tomaschitz A Vitamin D and prevention of diabetes: is lifelong endogenous vitamin D needed?. Lancet Diabetes Endocrinol 2014, 2:267-268.
3. Boucher BJ Vitamin D insufficiency and diabetes risks. Curr Drug Targets 2011, 12:61-87.
4. Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, Wareham NJ Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 2012, 55:2173-2182.
5. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJW Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 1995, 38:1239-1245.